Nisoldipine 1987 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Nisoldipine 1987 PDF full book. Access full book title Nisoldipine 1987 by P. G. Hugenholtz. Download full books in PDF and EPUB format.
Author: P. G. Hugenholtz
Publisher:
ISBN: 9783540183945
Category : Calcium
Languages : en
Pages : 0
Get Book Here
Book Description
Author: P. G. Hugenholtz
Publisher:
ISBN: 9783642730115
Category :
Languages : en
Pages : 372
Get Book Here
Book Description
Author: P. G. Hugenholtz
Publisher:
ISBN: 9783540183945
Category : Calcium
Languages : en
Pages : 0
Get Book Here
Book Description
Author: M.F. Rousseau
Publisher: Springer Science & Business Media
ISBN: 3642602207
Category : Medical
Languages : en
Pages : 83
Get Book Here
Book Description
Nisoldipine, a second generation of dihydropyridine derivative, exhibits high vascular and coronary selectivity. This monography focuses on the pharmacologic profile of Nisoldipine Coat-Core, a new galenic form, and its beneficial role in various clinical aspects of myocardial ischemia. The contributors are experts in the field of calcium antagonists.
Author: J. Meyer
Publisher:
ISBN: 9780387183947
Category : Calcium
Languages : en
Pages : 348
Get Book Here
Book Description
Author: Lionel H. Opie
Publisher: Springer Science & Business Media
ISBN: 1461308631
Category : Medical
Languages : en
Pages : 315
Get Book Here
Book Description
Calcium antagonists are now regarded as the most important advance in cardiac drug therapy since the advent of beta-adrenergic blocking agents. Acting ba sically as vasodilators-though with many other com plex mechanisms especially in the case of the anti arrhythmic calcium antagonists, these agents have grown in importance to become among the therapeutic agents of first choice for angina pectoris and hyper tension. The major aim of the present book is to present the clinician with the information needed for the practical use of calcium antagonists. What do all the numerous and often conflicting trials say? Do these agents really work? If so, which agent and in what dose? How do the three front runners, verapamil, nifedipine and diltia zem compare in the efficacy and side-effects with each other? How do the new second generation agents, now entering the North American market, slot in and com pare with the three first-liners? When the gloss is taken away from the advertisements, what is really left? The strong clinical bias of the present book should be complimented by further reading of books slanted towards fundamentals. One of the most important and recent of these is that by Dr Winifred Nayler (Calcium Antagonists, Academic Press, 1988). That book should be basic for essential background knowledge in the area of calcium antagonists. The important basic contribu tions of Fleckenstein deserve emphasis.
Author: T.v. Arnim
Publisher: Springer Science & Business Media
ISBN: 3662094347
Category : Medical
Languages : en
Pages : 193
Get Book Here
Book Description
"Predisposing conditions for acute ischemic syndromes" contains the proceedings of a conference held in Garmisch-Partenkirchcn, West Germany, October 14 and 15, 1988. The editors of this volume arc most grateful to the authors for their effort to provide manuscripts before the meeting, to the sponsor, Bayer AG, for their gen erous support, and to the publishers for the efficient collaboration, all of which have made the appearance of this book possible. All authors contributed their manu scripts in advance and they arc combined with an edited version orlhe discussions to allow rapid publication. In coronary heart disease the prognosis for patients is largely determined by the occurrence of irreversible ischemic damage to the myocardium. Irreversible eveniS are certainly preceded by a destabilization of a former stable situation. This desta bilization may occur with increasing symptomatology or without apparent warning signs to patient and physician; it may occur over a longer time period or very sud denly. The statemenl, however, holds true that no patient has ever died from stable angina pectoris. Thus, if the prognosis for patients with ischemic heart disease is to be improved, the focus has to be set on recognition and treatment of unstable ischemic syndromes. It was the goal of the conference to gather scientists and clinicans from different fields of research, to get an up-to-date view of the different aspects of unstable ischemic syndromes and to foster interdisciplinary discussions.
Author: Basil S. Lewis
Publisher: Springer Science & Business Media
ISBN: 3642582311
Category : Medical
Languages : en
Pages : 713
Get Book Here
Book Description
Following remarkable advances in medical care. the past decade has witnessed a significant improvement in the survival of patients with many different forms of heart disease. In the majority ofcases. however. the advances have been pa lIiative and not curative. The resu It has been the prod uction of an ever-increasing population of patients with heart disease. many of whom suffer from myocardial dysfunction and latent or overt heart failure. Heart failure is now a major cause of morbidity and mortality in cardiac patients. This book aims to combine in a single volume data relating to both pathophysiological mechanisms and the clinical management of the patient with heart failure. It includes chapters dealing with molecular. biochemical. and pathophysiological aspects of heart failure. ven tricular function and its assessment. and the clinical aspects of heart failure in different cardiac disorders, including ischemic heart disease. valvular heart disease. and the cardiomyopathies. There are sections on pharmacotherapy. the role of arrhythmias, exercise physiology. and neurohumoral mechanisms. The book also deals with newer inter ventional techniques. newer surgical procedures and some current problems relating to cardiac assist devices and heart and heart-lungs transplantation.
Author: Paul R. Lichtlen
Publisher:
ISBN:
Category : Calcium
Languages : en
Pages : 168
Get Book Here
Book Description
Author: Wolf-Dieter Busse
Publisher: Springer Science & Business Media
ISBN: 3642957161
Category : Medical
Languages : en
Pages : 131
Get Book Here
Book Description
This volume reviews important milestones in the history of the development of 1,4-dihydropyridines starting in the late 1960s. The discovery led to theestablishment of Ca2+ antagonists as leading cardiovascular drugs throughoutthe world. This volume includes presentations of the results of some recent collaborative extramural studies by American investigators.
Author: G. Heusch
Publisher: Springer Science & Business Media
ISBN: 364254133X
Category : Medical
Languages : en
Pages : 573
Get Book Here
Book Description
Ischemie heart disease is still the most frequent cause of death in the western world. There have been significant achievements in diagnostic procedures as well as in the medical, invasive, and surgiealtreatment ofischemieheart disease inrecent years. A variety ofdrugs are availablefor the pharmacotherapyofischemieheart disease, par ticularly nitrates, ß-blockers, and calcium-antagonists which are used as mono therapy or in various combinations. However, the selection of patients for a certain treatment, as weIl as the optimization of an individual treatment are still largely empirical. On the other hand, the recent advances in experimental cardiology emphasize the extremely complex and dynamie scenario of ischemic heart disease, involving endothelial damage, coagulation processes, metabolie and morphologie derangements, coronary constrictor mechanisms, blood flow redistribution, arrhythmogenesis, contraetile dysfunction during ischemia and reperfusion, and finally lack or presence of pain perception. Therefore, it appears desirable to close the gap between experimental and clinical cardiology and, thus, to provide a pathophysiologieal basis for rational cliniealdecisions with respect to diagnostic and therapeutic procedures. The idea for this book arose during the preparation of a seminar series on experi mental cardiology, when I found it diffieultto collect the pertinentinformation from textbooks of cardiology, physiology, pathology, and pharmacology, as well as from numerous review and original artieies on specifictopies. I am now very grateful that expert cliniealand experimental colleagues from around the world have joined me in the effort to provide a comprehensive textbook on the pathophysiology of myocar dial ischemia and its rational pharmacotherapy.
